Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125219541 | 12521954 | 1 | I | 20160623 | 20160701 | 20160701 | EXP | CN-ASTRAZENECA-2016SE70427 | ASTRAZENECA | 74.00 | YR | F | Y | 0.00000 | 20160701 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125219541 | 12521954 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 270 | UG | Y | U | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||
| 125219541 | 12521954 | 2 | C | INSULIN | INSULIN NOS | 1 | Subcutaneous | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125219541 | 12521954 | 1 | Diabetes mellitus |
| 125219541 | 12521954 | 2 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125219541 | 12521954 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125219541 | 12521954 | Blood glucose increased | |
| 125219541 | 12521954 | Decreased appetite |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125219541 | 12521954 | 1 | 20160526 | 20160621 | 0 |